Search company, investor...

PatentFlow Technology

patientflowtech.com

Stage

Other Investors | Acquired

About PatentFlow Technology

PatentFlow Technology assists hospitals and other healthcare organizations in managing patient flow issues by providing consulting services and implementing software solutions. The technologies and services lead to reduced waiting times, reduced operating costs and enhanced quality of care. Patient Flow Technology was acquired by Press Ganey in January 2009.

Headquarters Location

8 Saint Marys St # 6

Boston, Massachusetts, 02215,

United States

617-358-5060

Missing: PatentFlow Technology's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: PatentFlow Technology's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

PatentFlow Technology Frequently Asked Questions (FAQ)

  • Where is PatentFlow Technology's headquarters?

    PatentFlow Technology's headquarters is located at 8 Saint Marys St # 6, Boston.

  • What is PatentFlow Technology's latest funding round?

    PatentFlow Technology's latest funding round is Other Investors.

  • Who are the investors of PatentFlow Technology?

    Investors of PatentFlow Technology include Boston University Technology Development.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.